[摘要] 目的 考察溫針灸治療原發(fā)性痛經(jīng)的臨床效果與安全性評(píng)價(jià)。 方法 選取2017年1～10月我院治療的寒凝血瘀型原發(fā)性痛經(jīng)患者78例，隨機(jī)分為研究組（39例）和對(duì)照組（39例），研究組患者給予溫針灸治療，對(duì)照組患者給予口服布洛芬緩釋膠囊進(jìn)行治療，比較兩組患者的臨床治療效果及不良反應(yīng)的發(fā)生率，并檢測(cè)兩組患者治療前后疼痛視覺模擬評(píng)分（visual analogue scale，VAS）及血清內(nèi)的前列環(huán)素E2的水平。結(jié)果 研究組患者治療的總有效率為94.87%，對(duì)照組為76.92%，兩組相比差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）；治療前，兩組患者的VAS評(píng)分和PGE2水平相比，差異均無統(tǒng)計(jì)學(xué)意義（P>0.05）；治療后，與對(duì)照組相比，研究組患者的VAS評(píng)分和PGE2水平均顯著降低，差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）；研究組患者治療期間不良反應(yīng)的總發(fā)生率為4例（10.26%），對(duì)照組為11例（28.21%），兩組相比，差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 溫針灸治療寒凝血瘀型原發(fā)性痛經(jīng)的臨床效果較好，且安全性較高。
　　[關(guān)鍵詞] 溫針灸；原發(fā)性痛經(jīng)；寒凝血瘀型；VAS評(píng)分
　　[中圖分類號(hào)] R245 [文獻(xiàn)標(biāo)識(shí)碼] B [文章編號(hào)] 1673-9701（2018）08-0134-03
　　Clinical effect and safety evaluation of needle warming moxibustion in treating primary dysmenorrhea
　　LU Yu 1，2 MA Ruifen 2 QIAN Li1
　　1.Department of Obstetrics and Gynecology， Jiashan Chinese Medicine Hospital in Zhejiang Province， Jiashan 314100， China； 2.Department of Obstetrics and Gynecology， Jiaxing Chinese Medicine Hospital in Zhejiang Province， Jiaxing 314001， China
　　[Abstract] Objective To investigate the clinical efficacy and safety of needle warming moxibustion in the treatment of primary dysmenorrhea. Methods 78 patients with primary dysmenorrhea of type of cold coagulation and blood stasis in our hospital from January to October 2017 were randomly divided into study group（39 cases） and control group （39 cases）. The study group was given needle warming moxibustion. The patients in the control group were given oral sustained-release ibuprofen capsules for treatment. The clinical efficacy and the incidence of adverse reactions were compared between the two groups. The visual analogue scale（VAS） and serum prostacyclin E2 level were detected before and after the treatment. Results The total effective rate of treatment was 37 cases（94.87%） in the study group and 30 cases （76.92%） in the control group， where the difference was statistically significant（P<0.05）. There was no significant difference between the two groups in VAS score and PGE2 level（P>0.05） before treatment. While after treatment， the VAS score and the PGE2 level in study group were significantly decreased compared with control group， where the difference was statistically significant（P<0.05）. The total incidence of adverse reactions in study group was 4 cases （10.26%） during the treatment period， while the incidence of adverse reactions in the control group was 11 cases （28.21%）. The difference was statistically significant（P<0.05）. Conclusion Needle warming moxibustion treatment for primary dysmenorrhea with the type of cold coagulation and blood stasis showed better clinical efficacy and higher safety.

相關(guān)熱詞搜索：原發(fā)性 痛經(jīng) 針灸 臨床 效果